Skip to main content
    H

    HCA Healthcare, Inc. (HCA)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $511.78
    +12.73 (+2.55%)

    Market Cap: $104.25B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    HCA Healthcare, Inc. (HCA) Earnings: Report Dates and Results

    Updated Oct 27, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    HCA Healthcare (HCA) is expected to report earnings on Jan 25, 2027. In the quarter ended Sep 30, 2026, HCA Healthcare reported EPS of $7.22, above the $6.74 estimate. It beat the EPS estimate in each of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    70%(28/40)
    Avg Surprise
    +20.68%
    Streak
    8 Q

    Upcoming Estimates

    Reports Jan 25, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$8.28
    Range$7.72 - $8.94
    24 analysts
    Revenue Consensus
    $20.22B
    Range$19.30B - $21.30B
    23 analysts
    Reports Apr 22, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$7.49
    Range$6.93 - $7.94
    13 analysts
    EPS Revisions
    1
    9
    30d
    EPS Estimate DriftChange to current
    90d ago$7.81-4.0%
    60d ago$7.82-4.2%
    30d ago$7.84-4.4%
    7d ago$7.52-0.3%
    Current$7.49
    Revenue Consensus
    $19.88B
    Range$19.66B - $20.09B
    12 analysts

    Next Report

    HCA has an expected report date of Jan 25, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 3.4% above the $8.01 reported for the quarter ended Dec 31, 2025.

    HCA Earnings Call

    The latest HCA earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, HCA beat 28, missed 9 and matched 3. Revenue for the quarter ended Sep 30, 2026 was $19.85B, up 3.6% from $19.16B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$7.22$6.74$5.83 - $7.35+7.12%Beat+3.7%200 up, 3 downOct 27, 2026$19.85B
    Jun 30, 2026$7.59$7.57$7.28 - $7.62+0.26%Beat+11.0%151 up, 1 downJul 24, 2026$20.23B
    Mar 31, 2026$7.15$7.13$6.72 - $7.65+0.28%Beat+10.9%190 up, 2 downApr 24, 2026$19.11B
    Dec 31, 2025$8.01$7.48$7.18 - $7.71+7.09%Beat+28.8%2011 up, 7 downJan 27, 2026$19.51B
    Sep 30, 2025$6.96$5.73$5.38 - $5.98+21.47%Beat+42.0%192 up, 3 downOct 24, 2025$19.16B
    Jun 30, 2025$6.84$6.32$5.98 - $6.70+8.23%Beat+24.4%191 up, 2 downJul 25, 2025$18.61B
    Mar 31, 2025$6.45$5.75$5.48 - $5.95+12.17%Beat+20.3%190 up, 1 downApr 25, 2025$18.32B
    Dec 31, 2024$6.22$6.14$5.84 - $7.04+1.30%Beat+5.4%180 up, 1 downJan 24, 2025$18.29B
    Sep 30, 2024$4.90$4.98$4.75 - $5.55-1.61%Miss+25.3%142 up, 0 downOct 25, 2024$17.49B
    Jun 30, 2024$5.50$4.93$4.15 - $5.44+11.56%Beat+28.2%163 up, 0 downJul 23, 2024$17.49B
    Mar 31, 2024$5.36$5.09$4.02 - $5.69+5.30%Beat+8.7%172 up, 0 downApr 26, 2024$17.34B
    Dec 31, 2023$5.90$5.05$4.91 - $5.37+16.83%Beat+27.2%151 up, 0 downJan 30, 2024$17.30B
    Sep 30, 2023$3.91$3.97$3.72 - $4.32-1.51%Miss-0.5%151 up, 1 downOct 24, 2023$16.21B
    Jun 30, 2023$4.29$4.24$3.93 - $4.37+1.18%Beat+1.9%161 up, 0 downJul 27, 2023$15.86B
    Mar 31, 2023$4.93$3.92$3.46 - $4.20+25.77%Beat+19.7%193 up, 2 downApr 21, 2023$15.59B
    Dec 31, 2022$4.64$4.79$4.34 - $5.27-3.13%Miss+5.0%182 up, 0 downJan 27, 2023$15.50B
    Sep 30, 2022$3.93$3.86$3.61 - $4.24+1.81%Beat-14.0%202 up, 0 downOct 21, 2022$14.97B
    Jun 30, 2022$4.21$3.71$3.15 - $4.14+13.48%Beat-3.7%211 up, 1 downJul 22, 2022$14.82B
    Mar 31, 2022$4.12$4.24$3.84 - $4.60-2.83%Miss-0.5%200 up, 1 downApr 22, 2022$14.95B
    Dec 31, 2021$4.42$4.52$4.18 - $5.21-2.21%Miss+7.0%211 up, 0 downJan 27, 2022$15.06B
    Sep 30, 2021$4.57$4.01$3.55 - $5.90+13.97%Beat+138.0%21N/AOct 22, 2021$15.28B
    Jun 30, 2021$4.37$3.16$2.74 - $3.64+38.29%Beat+191.3%19N/AJul 20, 2021$14.44B
    Mar 31, 2021$4.14$3.33$2.88 - $3.79+24.32%Beat+77.7%17N/AApr 22, 2021$13.98B
    Dec 31, 2020$4.13$3.59$3.24 - $4.05+15.04%Beat+33.7%18N/AFeb 2, 2021$14.29B
    Sep 30, 2020$1.92$2.26$1.68 - $4.80-15.04%Miss-13.9%18N/AOct 26, 2020$13.31B
    Jun 30, 2020$1.50-$0.33-$2.66 - $1.22+554.55%Beat-32.1%18N/AJul 22, 2020$11.07B
    Mar 31, 2020$2.33$2.65$1.10 - $3.04-12.08%Miss-21.5%20N/AApr 21, 2020$12.86B
    Dec 31, 2019$3.09$3.09$2.89 - $3.250.00%In line+3.3%23N/AJan 28, 2020$13.52B
    Sep 30, 2019$2.23$2.13$1.92 - $2.31+4.69%Beat+3.2%23N/AOct 29, 2019$12.69B
    Jun 30, 2019$2.21$2.46$2.25 - $2.70-10.16%Miss-3.5%22N/AJul 30, 2019$12.60B
    Mar 31, 2019$2.97$2.33$2.16 - $2.55+27.47%Beat+27.5%22N/AApr 30, 2019$12.52B
    Dec 31, 2018$2.99$2.58$2.46 - $2.71+15.89%Beat+40.4%24N/AJan 29, 2019$12.27B
    Sep 30, 2018$2.16$1.91$1.61 - $2.09+13.09%Beat+78.5%20N/AOct 30, 2018$11.45B
    Jun 30, 2018$2.29$2.16$2.04 - $2.35+6.02%Beat+30.9%20N/AJul 25, 2018$11.53B
    Mar 31, 2018$2.33$2.07$1.93 - $2.40+12.56%Beat+33.9%21N/AMay 1, 2018$11.42B
    Dec 31, 2017$2.13$1.88$1.77 - $2.04+13.30%Beat+12.7%21N/AJan 30, 2018$11.56B
    Sep 30, 2017$1.21$1.21N/A0.00%In line-24.8%18N/AOct 31, 2017$10.70B
    Jun 30, 2017$1.75$1.81$1.70 - $1.89-3.31%Miss+5.4%22N/AJul 25, 2017$10.73B
    Mar 31, 2017$1.74$1.74N/A0.00%In line+1.8%N/AN/AMay 2, 2017$10.62B
    Dec 31, 2016$1.89$1.78N/A+6.18%Beat+11.8%N/AN/AJan 31, 2017$8.25B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $28.26, up 28.6% from the year before. It was $6.87 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$28.26+28.6%
    Dec 31, 2024$21.98+15.5%
    Dec 31, 2023$19.03+12.6%
    Dec 31, 2022$16.90-3.4%
    Dec 31, 2021$17.50+77.1%
    Dec 31, 2020$9.88-5.9%
    Dec 31, 2019$10.50+7.5%
    Dec 31, 2018$9.77+43.0%
    Dec 31, 2017$6.83N/A
    Dec 31, 2016$6.87N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,500 words across 23 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,45723
    2026Q2Jun 30, 20267,05820
    2026Q1Mar 31, 20268,32320
    2025Q4Dec 31, 20258,76820
    2025Q3Sep 30, 20254,07210
    2025Q2Jun 30, 20257,57420
    2025Q1Mar 31, 20258,45121
    2024Q4Dec 31, 20248,21922

    2026Q3 Earnings Call

    Opening remarks

    Frank George Morgan Vice President of Investor Relations Good morning, and welcome to everyone on today's call. With me this morning is our CEO, Samuel N. Hazen, and our CFO, Michael A. Marks. Samuel and Mike will provide some prepared remarks, and then we will take your questions. Before I turn the call over to Samuel, let me remind everyone that should today's call contain any forward-looking statements, they are based on management's current expectations. Numerous risks, uncertainties, and other factors may cause actual results to differ materially from those that might be expressed today. More information on forward-looking statements and these factors is listed in today's press release and in our various SEC filings. On this morning's call, we may reference measures such as adjusted EBITDA, which is a non-GAAP financial measure. A table providing supplemental information on adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc., is included in today's release. This morning's call is being recorded, and a replay of the call will be available later today. With that, I will now turn the call over to Samuel N. Hazen.

    Samuel N. Hazen CEO Good morning, and thank you for joining the call. The company's results in the third quarter reflected improvement in key areas of our business. First, demand for our services continued to grow at a solid rate. Adjusted admissions on a same-facility basis grew 3%, compared to 2.3% year to date. Within this growth, insured volumes grew faster in the quarter than in the first half of the year. The third quarter reflected the 22nd consecutive quarter of volume growth for the company. Second, revenue per adjusted admission for our insured business, excluding supplemental payments, increased at a higher rate than in the first half of the year. This increase partially offset the payer-mix pressure from continued volume declines for patients who were formerly covered in health insurance exchanges and are now uninsured. Additionally, we had a modest incremental net benefit of $50 million in the quarter from Medicaid supplemental payment programs, primarily related to a recently approved Virginia program. These factors, coupled with improved cost results, contributed to solid financial performance in the quarter that slightly exceeded our expectations. Diluted earnings per share, as adjusted, increased almost 4%. I have often mentioned that HCA has strong staying power because of our scale, the important role we play in providing services to communities, and our disciplined culture. Despite the challenges this year brought about by federal policy changes, we have continued to move the company forward and believe we are positioned to end the year positively. As we look ahead to 2027, let me share a few preliminary observations around certain aspects of our business before we provide our full-year guidance in January.

    Frequently Asked Questions About HCA

    When is HCA Healthcare's next earnings date?

    HCA Healthcare's next earnings report is expected for Jan 25, 2027.

    Did HCA beat earnings estimates last quarter?

    Yes. HCA Healthcare reported EPS of $7.22 for the quarter ended Sep 30, 2026, above the $6.74 estimate, a 7.12% surprise.

    What EPS do analysts expect from HCA next quarter?

    The consensus EPS estimate for HCA Healthcare for the quarter ending Dec 31, 2026 is $8.28 from 24 analysts, with estimates from $7.72 to $8.94.

    How often does HCA beat earnings estimates?

    HCA Healthcare beat the EPS estimate in each of the last 8 quarters, with an average surprise of +7.24%.